Co-diagnostics, Inc. · NASDAQ:CODX
Egan Dwight H received 4,584 Co-diagnostics, Inc. shares as an award (Form 4)
Traded May 23, 2026 · Filed May 27, 2026
On May 23, 2026, Egan Dwight H (Director, Chief Executive Officer) received 4,584 Co-diagnostics, Inc. shares as an award, leaving 27,893 shares. Filed May 27, 2026 (Form 4).
- Awarded
- 4,584 shares
- Holding after
- 27,893 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 23, 2026 | Common Stock | Award | 4,584 | 29,526 | Direct | |
| May 23, 2026 | Common Stock | Disposition | 1,633 | US$5.07 | 27,893 | Direct |
Source
Related
- Co-diagnostics, Inc.
- Egan Dwight H
- Co-diagnostics, Inc. shareholders
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Jane Street Group, LLC · Aug 10, 2026
- Schedule 13G · Jane Street Group, LLC · Jun 3, 2026
- Form 4 · Brown Brian Lee · May 27, 2026
- Form 4 · Abbott Richard David · May 27, 2026